Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Read Article
News
2024
2023
Archive
Search news articles
March 1, 2023
Cidara Therapeutics Announces Promising Interim Phase 2a Data Assessing the Safety and Efficacy of a Single Dose of CD388 in an Influenza Challenge Model
February 27, 2023
Escient Pharmaceuticals Announces Oral Presentation of Data Highlighting the Preclinical Pharmacology of EP262 at the American Academy of Allergy, Asthma and Immunology Annual Meeting
February 27, 2023
EyePoint and Rallybio Announce Research Collaboration to Evaluate Rallybio’s Inhibitor of Complement Component 5 (C5) and EyePoint’s Proprietary Durasert® Technology for Sustained Intraocular Delivery in Geographic Atrophy
February 24, 2023
Enliven Therapeutics Closes Merger with Imara and Private Placement of $165 Million
February 22, 2023
Homology Medicines Presents Preclinical Data Supporting Immunosuppression Regimen in Ongoing PKU and Hunter Syndrome Clinical Trials, and Details Optimized MLD Gene Therapy Candidate at the 19th Annual WORLDSymposium™ Meeting
February 22, 2023
Radionetics Oncology Appoints Istvan Molnar, M.D. as Chief Medical Officer
February 21, 2023
scPharmaceuticals Announces Launch and Commercial Availability of FUROSCIX® (furosemide injection)
February 16, 2023
First AML Patient Transplanted with Vor Bio’s Trem-cel Demonstrated Durable Engraftment through Multiple Mylotarg™ Cycles at Initial Dose Level
February 9, 2023
Ensoma Announces Closing of Twelve Bio Acquisition
February 9, 2023
Entrada Therapeutics Closes Agreement with Vertex to Discover and Develop Endosomal Escape Vehicle-Therapeutics for Myotonic Dystrophy Type 1 (DM1)
« Previous Page
1
…
11
12
13
14
15
…
119
Next Page »